HLA-B and type 1 diabetes mellitus: Regarding our results concerning the ability of peptides derived from beta cell autoantigens to bind to the HLA-B allotypes studied here (Table 2), one must appreciate that peptide binding is a double-edged sword in terms of T1D pathogenesis.